Stephen From, President and CEO at EYEGATE PHARMACEUTICALS INC (EYEG), bought 15,000 shares at $1.49 ($22K) on 2016-09-15, disclosed to the SEC on 2016-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |